Dana Q1 Adjusted EBITDA Rises to $171 Million; Full-Year Guidance Maintained
Dana reported first-quarter 2026 sales of $1.87 billion, up from $1.78 billion a year earlier, and adjusted EBITDA of $171 million, up from $93 million, with the margin rising to 9.2% from 5.2%. The company maintained its full-year 2026 guidance and said it won a new Stellantis program, but operating cash flow and adjusted free cash flow were both negative and worse than a year earlier.
Key points
- Q1 2026 sales of $1.87 billion vs. $1.78 billion in Q1 2025, driven by customer recoveries and currency translation
- Adjusted EBITDA of $171 million, a 9.2% margin, vs. $93 million and 5.2% in Q1 2025; cost savings were the primary driver
- Operating cash flow was a use of $156 million and adjusted free cash flow a use of $195 million, vs. uses of $37 million and $101 million a year earlier
- Full-year 2026 guidance: sales $7.30 to $7.70 billion, adjusted EBITDA $750 to $850 million, diluted adjusted EPS $2.00 to $3.00, adjusted free cash flow $250 to $350 million
The filing
Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 29, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.